Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	89.77B
Revenue (ttm)	55.55B
Net Income (ttm)	2.36B
Shares Out	n/a
EPS (ttm)	2.04
PE Ratio	38.02
Forward PE	9.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,470,440
Average Volume	2,154,594
Open	7,944.00
Previous Close	7,867.00
Day's Range	7,721.00 - 8,013.00
52-Week Range	4,865.00 - 8,431.00
Beta	0.71
RSI	82.47
Earnings Date	Nov 5, 2025

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

In 2024, TLV:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD